National Bank of Canada
MRTX

National Bank of Canada’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

National Bank of Canada’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-473,500
Closed -$28M – 2982
2023
Q4 		$28M Buy
+473,500
New +$26.6M 0.04% 336
2023
Q3 		– Sell
-89,000
Closed -$3.39M – 2915
2023
Q2 		$3.39M Sell
89,000
-252,200
-74% -$10.4M 0.01% 827
2023
Q1 		$12.7M Sell
341,200
-26,100
-7% -$1.17M 0.03% 376
2022
Q4 		$16.6M Buy
367,300
+115,300
+46% +$7.46M 0.04% 301
2022
Q3 		$17.6M Sell
252,000
-247,000
-49% -$18.3M 0.09% 233
2022
Q2 		$33.5M Buy
499,000
+498,854
+341,681% +$31.7M 0.15% 149
2022
Q1 		$12K Sell
146
-49,000
-100% -$5.01M ﹤0.01% 2334
2021
Q4 		$7.21M Buy
+49,146
New +$7.63M 0.02% 464

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

National Bank of Canada's MRTX Position: Q1 2024 in Review

National Bank of Canada sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 473,500 shares — an estimated $28M sold.

National Bank of Canada first reported a position in MRTX in Q4 2021 and held it in 8 quarters. The position peaked at $33.5M in Q2 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • National Bank of Canada reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • National Bank of Canada sold 473,500 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $28M.
  • National Bank of Canada first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • National Bank of Canada's Mirati Therapeutics, Inc. Common Stock position peaked at $33.5M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on National Bank of Canada's 13F filing for Q1 2024, filed 13 May 2024.